Stockreport

Loss-Making UroGen Pharma Ltd. (NASDAQ:URGN) Expected To Breakeven In The Medium-Term [Yahoo! Finance]

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF UroGen Pharma Ltd. engages in the development and commercialization of solutions for urothelial and specialty cancers. With the latest financial year loss of US$127m and [Read more]